KR20100125318A - 안과용 플루오로퀴놀론 유도체 - Google Patents

안과용 플루오로퀴놀론 유도체 Download PDF

Info

Publication number
KR20100125318A
KR20100125318A KR1020107020529A KR20107020529A KR20100125318A KR 20100125318 A KR20100125318 A KR 20100125318A KR 1020107020529 A KR1020107020529 A KR 1020107020529A KR 20107020529 A KR20107020529 A KR 20107020529A KR 20100125318 A KR20100125318 A KR 20100125318A
Authority
KR
South Korea
Prior art keywords
composition
compound
fluoroquinolone
concentration
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020107020529A
Other languages
English (en)
Korean (ko)
Inventor
제프리 로버트 오웬
에이미 씨. 브룩스
리나 에프. 버널-페레즈
데이비드 더블유. 스트로만
조셉 제이. 다직스
Original Assignee
알콘 리서치, 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알콘 리서치, 리미티드 filed Critical 알콘 리서치, 리미티드
Publication of KR20100125318A publication Critical patent/KR20100125318A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1020107020529A 2008-02-15 2009-02-16 안과용 플루오로퀴놀론 유도체 Withdrawn KR20100125318A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2918008P 2008-02-15 2008-02-15
US61/029,180 2008-02-15

Publications (1)

Publication Number Publication Date
KR20100125318A true KR20100125318A (ko) 2010-11-30

Family

ID=40551911

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107020529A Withdrawn KR20100125318A (ko) 2008-02-15 2009-02-16 안과용 플루오로퀴놀론 유도체

Country Status (11)

Country Link
US (3) US20090209574A1 (cg-RX-API-DMAC7.html)
EP (1) EP2249836A1 (cg-RX-API-DMAC7.html)
JP (1) JP2011512362A (cg-RX-API-DMAC7.html)
KR (1) KR20100125318A (cg-RX-API-DMAC7.html)
CN (1) CN101977604A (cg-RX-API-DMAC7.html)
AU (1) AU2009214461A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0907511A2 (cg-RX-API-DMAC7.html)
CA (1) CA2714580A1 (cg-RX-API-DMAC7.html)
MX (1) MX2010008927A (cg-RX-API-DMAC7.html)
WO (1) WO2009103053A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201005790B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
WO2013085769A1 (en) 2011-12-06 2013-06-13 Alcon Research, Ltd. Cellulosic gel composition with improved viscosity stability
US9504691B2 (en) * 2012-12-06 2016-11-29 Alcon Research, Ltd. Finafloxacin suspension compositions
WO2014207769A1 (en) 2013-06-27 2014-12-31 Mylan Laboratories Ltd Process for the preparation of nepafenac
WO2017151664A1 (en) * 2016-02-29 2017-09-08 Belmont University Pharmaceutical compositions for fluoroquinolone drug delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880517A (en) * 1984-10-01 1989-11-14 Eltech Systems Corporation Catalytic polymer electrode for cathodic protection and cathodic protection system comprising same
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US6440964B1 (en) * 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
US6740664B2 (en) * 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
US6716830B2 (en) * 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections

Also Published As

Publication number Publication date
US20110160172A1 (en) 2011-06-30
ZA201005790B (en) 2011-10-26
AU2009214461A1 (en) 2009-08-20
BRPI0907511A2 (pt) 2015-07-21
US20090209574A1 (en) 2009-08-20
CA2714580A1 (en) 2009-08-20
EP2249836A1 (en) 2010-11-17
US20120108557A1 (en) 2012-05-03
WO2009103053A1 (en) 2009-08-20
JP2011512362A (ja) 2011-04-21
MX2010008927A (es) 2010-09-09
CN101977604A (zh) 2011-02-16

Similar Documents

Publication Publication Date Title
AU2022204216B2 (en) Compositions and methods of using nintedanib for improving glaucoma surgery success
US6492361B1 (en) Antibiotic compositions and methods for using same
US8450311B2 (en) Pharmaceutical compositions containing a fluoroquinolone antibiotic drug
WO2017066052A1 (en) Formulations and methods for treating high intraocular pressure
US20120108557A1 (en) Fluoroquinolone derivatives for ophthalmic applications
US20090209599A1 (en) Eye drop containing roflumilast
RU2434633C2 (ru) Фармацевтические препаративные формы латрункулина
JPWO2006049250A1 (ja) 眼内移行性促進水性点眼剤
EP4099986B1 (en) Xanthan-based ophthalmic topical formulations with a reduced dosage regimen
JP2024515714A (ja) 散瞳、緑内障、及び他の眼の病態を治療するための方法及び組成物
RU2836815C1 (ru) Офтальмологические композиции для местного применения на ксантановой основе с сокращенным режимом дозирования
KR20150090045A (ko) 피나플록사신 현탁 조성물
HK40100601A (en) Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
HK40000005B (en) Compositions and methods of using nintedanib for improving glaucoma surgery success

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20100914

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid